Klotho Neurosciences, Inc.
KLTO
$0.7488
$0.068810.12%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 511.66% | 482.71% | 817.19% | 570.40% | 110.58% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 529.99% | 482.71% | 817.19% | 570.40% | 110.58% |
| Operating Income | -529.99% | -482.71% | -817.19% | -570.40% | -110.58% |
| Income Before Tax | -714.37% | -538.96% | -769.30% | -514.62% | -104.22% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -714.37% | -538.96% | -769.30% | -514.62% | -104.22% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -714.37% | -538.96% | -769.30% | -514.62% | -104.22% |
| EBIT | -529.99% | -482.71% | -817.19% | -570.40% | -110.58% |
| EBITDA | -- | -- | -- | -- | -- |
| EPS Basic | -399.45% | -355.14% | -816.85% | -848.35% | -408.94% |
| Normalized Basic EPS | -398.77% | -354.91% | -819.37% | -846.20% | -408.93% |
| EPS Diluted | -391.09% | -346.76% | -772.94% | -846.76% | -420.67% |
| Normalized Diluted EPS | -398.77% | -354.91% | -819.37% | -846.20% | -408.93% |
| Average Basic Shares Outstanding | 72.57% | 43.94% | -93.15% | -97.05% | -98.06% |
| Average Diluted Shares Outstanding | 72.57% | 43.94% | -93.15% | -97.05% | -98.06% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |